Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

Healthcare Technology Drug Manufacturers - Specialty & Generic Software - Application Cannabis
GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

GB Group Ord Shs > Financials
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by pricecollectionon Feb 27, 2017 8:54am
121 Views
Post# 25897356

RE:RE:RE:Financials

RE:RE:RE:FinancialsNice work there farmer.


As for my opinion, i truly believe that cannimed will be the market leader when it comes to the medical side of the business. PErhaps, in the future, they may invest some money in acquiring a stake in an existing LP to have some exposure in the rec market. however, they wont do it by changing their brand image.

Like the ceo mentionned in the past, the rec market will be congested with several LP's. there will be lots of fierece compettition.

As for the medical side,with their gmp compliance, they will be able to service the medical sector as the needs of opiod based medciation is changing.

there are several catalysts on the way for cannimed

1- Q1 financial results. Looking good so far
2- LOI with cresco to supply the medical side to Europe
3- DEA application for license amendments in the usa to suply and perform research
4- Phase 2b trials!!!! huge for new medication... Rememeber there are only 3 phases and if approved, the medication will get marketed for sales.
5- Expansion of current facility
6-Completion of sub terra with michigan
7- US so far is more favorable to medical than recreational
8- health canada approval for Wafers with CTT pharma
9- Very low amount of shares available
10-Only 250 million cap !!!!


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities